Neuroimmunology researcher Eleftheria Kodosaki at Cardiff University discusses new research in mice that links Alzheimer’s disease with circadian rhythm. A good night’s sleep has…
Could the bacteria that causes gum disease also trigger Alzheimer’s? A drug candidate targeting this bacteria recently failed its early trials, but some experts…
The lack of effective treatments for Alzheimer’s have spurred scientists to rethink the dominant approach to tackling the disease: the amyloid hypothesis. This hypothesis…
Plagued by dementia symptoms for years, Michael Ellenbogen discusses the ongoing ambiguity surrounding his Alzheimer’s diagnosis. Michael Ellenbogen was reaching the height of his…
Here’s how VOA’s 5 founders — including reporter Phil Gutis — responded to recent Aduhelm Medicare announcement. A few months ago, I received an…
Nearly two full years into the COVID-19 pandemic, researchers are still in the process of learning what’s really going on inside the heads of…
UPDATE: 3 March 2024, 8:35 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Looking for brain fog remedies? Neurological experts offer six ways to speed up recovery from COVID-19’s neurological symptoms. Memory problems. Trouble focusing. Confusion. Mounting…
Vaccines are one of the greatest medical advances in history. This strategy is now being applied to the treatment and prevention of Alzheimer’s. We…
Scientists have their eyes set on spotting Alzheimer’s early. The earlier the disease can be diagnosed, the better the chance that a combination of…
On the brink of a new year, a note from Being Patient Founder and Editor-in-Chief Deborah Kan. Dear readers, As I reflect on 2021,…
Alzheimer’s is a notoriously difficult disease to identify with certainty. By the time a patient receives a diagnosis, its pathology in the brain is…
Protollin, a new vaccine for Alzheimer’s that is administered nasally, heads to human clinical trials. Through the incredible power of our immune system, researchers…
Roughly two thirds of Americans with Alzheimer’s are women, but it isn’t exactly clear why the disease disproportionately impacts females. Given that age is…
Beta-amyloid plaques are a hallmark of Alzheimer’s, but researchers have long been puzzled about why these plaques can also be found in the brains…